恆生科技指數一度漲4.5% 手機產業鏈股領漲
格隆匯11月9日丨港股科技股全線大漲,恆生科技指數一度漲4.57%,明顯強於恆指(+1.79%)和國企指數(+2%)。成分股中,比亞迪電子漲超9%,舜宇漲近9%(盤中一度大漲超13%創2018年6月以來新高價),金蝶國際、丘鈦科技、中興通訊漲超7%,中芯國際漲超6%。高通預計,2021年,5G智能手機出貨量將是2020年預期出貨量的兩倍多。到2022年,全球5G智能手機出貨量預計將達到7.5億部;到2023年,全球5G連接數預計將超過10億,比4G達到同樣連接數快2年;到2025年,全球5G連接數預計將接近30億,5G流量將佔全球移動網絡數據流量的45%。


Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.